Drug combined with care program better at reducing Alzheimer's symptoms than drug alone

Combining a specific care management program with a commonly-prescribed drug for Alzheimer’s, memantine, multiplies the medication’s ability to improve daily function by about 7.5 times, stalling some of the disease’s most damaging effects, according to new research. With no significant new drug for Alzheimer’s having been approved since 2003, the study authors say the time has come for the field to pay more attention to methods that can improve the impact of existing drugs.
Source: New feed

Leave a Reply

Your email address will not be published. Required fields are marked *